VinBigdata Institute under Vingroup on December 18 officially launched the largest biomedical data management and analysis system in Vietnam (https://genome.vinbigdata.org), Kinh te & Do thi Newspaper reported.
Built since June 2019, the system currently stores more than 1200 TeraBytes of data and nearly 5000 biological samples related to the 1000 Vietnamese genome projects and other application projects in accordance with the standards of the US National Institutes of Health (NIH).
Prof. Vu Ha Van speaks at the launching ceremony. Photo: Kinhtedothi.vn |
The design of the information security system follows the European General Information Security Regulation (GDPR).
It is expected that by the end of 2021, the system will update data sets from applied research projects on disease risks and drug effects by VinBigdata.
The system can store and process hundreds of PetaByte of data, as well as analyze the whole genome in less than 30 minutes, making it easy for parties to access, search, analyze and share data.
In the future, the project will become a valuable and reliable reference portal for Vietnamese people and the world biomedical research community.
On the same day, VinBigdata Big Data Institute announced its partnership with 10 leading prestigious research organizations in the world in the field of precision medicine.
The cooperation aims to promote research and accurate medical application in the diagnosis and treatment of cardiovascular disease, cancer, diabetes, among others.
Speaking at the signing ceremony, Prof. Vu Ha Van, Scientific Director of Vingroup Big Data Institute, said: “Vingroup will take advantage of global technological breakthroughs to promote research and development projects which will bring practical benefits to Vietnamese people."
For his part, Associate Professor Michael Winther from Lee Kong Chian Medical School under Nanyang Technological University (Singapore) said, on behalf of international partners, that this cooperation is essential for the advancement of genetic medicine in the region, as only when studying common and unique characteristics of each population, can scientists fully exploit the potential of genetic medicine.
